Molecular Chaperone Mechanisms in Parkinson's Disease

Parkinson’s disease is characterised by the progressive loss of dopaminergic neurons in the substantia nigra, coupled with the accumulation of misfolded α-synuclein into Lewy bodies. Molecular chaperones—among them the heat shock protein families HSP70, HSP90, small HSPs and the chaperonin CCT—play central roles in maintaining proteostasis by facilitating correct folding, preventing aggregation and targeting irreversibly misfolded species for degradation. Co-chaperones such as HSP40 (DNAJ proteins) and CHIP (C-terminus of HSP70-interacting protein) coordinate with core chaperones to determine whether client proteins are refolded or routed to proteasomal or lysosomal pathways. Chaperone-mediated autophagy and the ubiquitin–proteasome system collaborate to clear aberrant α-synuclein species, while specialised chaperome networks reorganise under stress to buffer against proteotoxic insults. Dysregulation of these systems—through age-related decline in chaperone capacity or sequestration of chaperones into aggregates—exacerbates protein misfolding, promotes prion-like spreading of α-synuclein and accelerates neuronal death. Understanding the mechanistic interplay between chaperones, co-chaperones and degradation pathways has thus become a priority for identifying disease-modifying strategies in Parkinson’s disease.

Research from Nature Portfolio

Recent studies have utilised human pluripotent stem cell-derived midbrain dopamine neurons coupled with chemical sensors of HSP90-incorporating chaperome networks to detect early pathogenic events in Parkinson’s disease. These approaches revealed that genetic and environmental stressors remodel stress-specific chaperome assemblies, triggering STAT3 and NF-κB signalling or aberrant phosphorylation of tyrosine hydroxylase. Pharmacological inhibition of the maladaptive chaperome reversed these signalling abnormalities and restored neuronal viability, highlighting a sensor-guided strategy for early intervention.

Investigations into the chaperonin CCT have demonstrated that its double-ring structure binds specifically to the central hydrophobic (NAC) region of the Parkinson’s-linked α-synuclein A53T mutant. This interaction prevents the growth of amyloid fibrils by stabilising early oligomeric conformations and mitigates oligomer toxicity in neuroblastoma cells. These findings position CCT as a selective modulator of amyloid assembly and a potential therapeutic target for synucleinopathies.

Molecular Chaperone Mechanisms in Parkinson's Disease publication trend

The graph below shows the total number of articles in molecular chaperone mechanisms in parkinson's disease across all publications each year (not limited to Nature Index journals).

Technical terms

α-synuclein: neuronal protein that aggregates into amyloid fibrils in Parkinson’s disease.

Molecular chaperone: protein that assists in folding, refolding or disposal of misfolded proteins.

Co-chaperone: accessory protein that regulates chaperone activity or substrate targeting.

Proteostasis: cellular network governing protein synthesis, folding and degradation.

Chaperome network: dynamic assembly of chaperones and co-chaperones responding to proteotoxic stress.

Chaperone-mediated autophagy: selective lysosomal pathway for degradation of chaperone-recognised proteins.

References

1. Exploring heat shock proteins as therapeutic targets for Parkinson’s disease. Biochemical Pharmacology (2024).
2. Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease. International Journal of Molecular Sciences (2023).
3. HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons. Nature Communications (2018).
4. The chaperonin CCT inhibits assembly of α-synuclein amyloid fibrils by a specific, conformation-dependent interaction. Scientific Reports (2017).
5. The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity. Journal of Biological Chemistry (2018).
6. The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates α-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways*. Journal of Biological Chemistry (2005).